• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Organ and Tissue Transplantation - Global Strategic Business Report Product Image

Organ and Tissue Transplantation - Global Strategic Business Report

  • ID: 595578
  • September 2014
  • Region: Global
  • 251 Pages
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • CryoLife, Inc.
  • Exactech, Inc.
  • Folio Biosciences
  • Köhler Chemie
  • LifeCell Corporation
  • MORE

This report analyzes the worldwide markets for Organ and Tissue Transplantation in Number of Procedures. The global and regional markets (except the US) for 'Organ and Tissue Transplantation' in this report are analyzed by the following Product Segments - Organ Tranplantation (Heart, Kidneys, Liver, Pancreas, and Lungs). The US market for 'Organ and Tissue Transplantation' in this report is analyzed by the following Product Segments: Organ Type (Heart, Kidneys, Liver, Pancreas, Lungs, and Intestine), Tissue Type (Cornea, Heart Valve, Skin Grafts, Vascular Grafts, Bone Marrow, and Bone Grafts), and Bone Graft Transplantation (By Graft Type: Autologous Graft, Allograft, and Other Materials; By Application Type: General Orthopedics, Spinal Fusions, and Cranio/Maxillofacial). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 24 companies including many key and niche players.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • CryoLife, Inc.
  • Exactech, Inc.
  • Folio Biosciences
  • Köhler Chemie
  • LifeCell Corporation
  • MORE

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definition and Scope of Study
Product Definitions
Organ Transplantation
Heart Transplantation
Kidney Transplantation
Liver Transplantation
Pancreas Transplantation
Small Intestine Transplantation
Lungs
Tissue Transplantation
Corneal Transplantation
Blood Stem Cell Transplantation
Bone Marrow Transplantation
Heart Valves Transplantation

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
A Quick Primer
Europe and the United States Lead the Global Organ Transplants Market
Table 1: Global Organ Transplants by Leading Country in Terms of No. of Transplants Per Million Population (PMP) for the Year 2012 (includes corresponding Graph/Chart)
Kidney and Liver Transplants Top the Organ Transplants Worldwide
Table 2: Global Kidney Transplants from Deceased Donor by Select Countries (2013): No. of Transplants Per Million Population (PMP) by Country (includes corresponding Graph/Chart)
Table 3: Global Kidney Transplants from Living Donor by Select Countries (2013): No. of Transplants per Million Population (PMP) by Country (includes corresponding Graph/Chart)
Table 4: Global Liver Transplants from Deceased Donor by Select Countries (2013): No. of Transplants per Million Population (PMP) by Country (includes corresponding Graph/Chart)
Table 5: Global Liver Transplants from Living Donor by Select Countries (2013): No. of Transplants per million population (PMP) by Country (includes corresponding Graph/Chart)
Table 6: Global Heart Transplants by Select Countries (2013): No. of Transplants Per million population (includes corresponding Graph/Chart)
Table 7: Global Lung Transplants by Select Countries (2013): Number of Transplants Per Million Population (includes corresponding Graph/Chart)
Table 8: Global Pancreas Transplants by Select Countries (2013): Number of Transplants Per Million Population (includes corresponding Graph/Chart)
Demand and Supply Imbalance
Table 9: European Organ Transplantation Waiting Lists: No. of Waiting Patients by Organ Type (2012) (includes corresponding Graph/Chart)
Table 10: US Waiting List of Patients for Organ Transplants by Organ Type: As of August 2014 (includes corresponding Graph/Chart)
Measures to Address Organ Shortage
Cardiac Arrest Death Patients: The Untapped Potential Donors
Table 11: Leading Countries in Terms of Number of Donors after Cardiac Death (DCD) in 2013 (includes corresponding Graph/Chart)
Donation after Circulatory Death - Rife with Ethical Issues
Living Donor Organs on the Rise
Table 12: Global Living Organ Donors by Leading Country in Terms of No. of Donors Per Million Population (PMP) for the Year 2013 (includes corresponding Graph/Chart)
Table 13: Global Deceased Organ Donors by Leading Country in Terms of No. of Donors Per Million Population (PMP) for the Year 2013 (includes corresponding Graph/Chart)
Transplantation - Expenditure and Regional Variations
Table 14: US Organ Transplantation Charges - Total Billed Charges per Transplant by Type (2011) (includes corresponding Graph/Chart)
Bone Grafts: An Overview
Table 15: Fractures by Age Group (2012): Percentage Share Breakdown of Number of Fractures by Age Group (includes corresponding Graph/Chart)
Table 16: Global Orthopedic Market by Segment (2013E): Percentage Breakdown of Value Sales for Spine, Trauma, Knees, Hips, Orthobiologics, Extremities and Others (includes corresponding Graph/Chart)
Key Statistics in Global Orthopedics Industry
Table 17: Worldwide Orthopedic Market (2013E): Percentage Market Share Breakdown of Value Sales by Company for DePuy Synthes, Stryker, Zimmer, Smith & Nephew, Medtronic, and Others (includes corresponding Graph/Chart)
Table 18: Worldwide Market for Orthopedic Implants in Spinal Procedures (2013E): Percentage Market Share Breakdown of Value Sales by Company for Medtronic, J&J and Others (includes corresponding Graph/Chart)
Table 19: Worldwide Market for Orthopedic Implants for Reconstructive Procedures (2013E): Percentage Market Share Breakdown of Value Sales by Company for Zimmer, J&J, Stryker, Biomet, Smith & Nephew, and Others (includes corresponding Graph/Chart)
Table 20: Worldwide Market for Orthopedic Implants for Trauma Procedures (2013E): Percentage Market Share Breakdown of Value Sales by Company for J&J, Stryker, Biomet Smith & Nephew, Zimmer, and Others (includes corresponding Graph/Chart)
Table 21: Global Joint Replacement Market (2013E): Percentage Market Share Breakdown of Sales for Zimmer, DePuy Synthes, Stryker, Biomet, Smith & Nephew, and Others (includes corresponding Graph/Chart)
Orthopedic Grafts - Regional Market Variations

2. MARKET TRENDS
Combined Organ Transplantation - Gaining Attention
Table 22: Multiple Organ Transplants in the US - No. of Transplants by Type (2010-2014)
Illegal Organ Trafficking - A Risky Proposition
Increasing Consent Rates - A Key Factor
Transplant Tourism - Creating Brighter Avenues
Alliances to Play a Key Role
Graying Population and Chronic Diseases Surge Need for Transplants
Table 23: Aged Population (65+ Years) as a Percentage of the Total Population: 2000 Vis-a-vis 2025 (includes corresponding Graph/Chart)
Table 24: Aged Population (65+ Years) as a Percentage of the Total Population by Region: 2000 Vis-a-vis 2025 (includes corresponding Graph/Chart)
Table 25: Global Aging Population by Age Group: 1975
(includes corresponding Graph/Chart)
Table 26: Aging Population by Age Group in More Developed Countries: 1975-2050 (includes corresponding Graph/Chart)
Table 27: Aging Population by Age Group in Less Developed Countries: 1975-2050 (includes corresponding Graph/Chart)
Table 28: Aging Population by Age Group in Least Developed Countries: 1975-2050 (includes corresponding Graph/Chart)
Rising Incidences of Degenerative Intervertebral Disc Diseases Promote Tissue Transplantation
Table 29: % of Women Affected by Osteoporosis (includes corresponding Graph/Chart)
Fetal Tissue for Bionic Devices - Assuming Importance
LVADs - Gaining Significance for Impending Heart Transplants
Stem Cell Based Bone Grafts - Fastest Growing Bone Graft Substitute Segment
Synthetic Bone Graft - The Latest Trend
Stem Cell Therapies - Expanding the Horizon of Transplantation
Rising Cancer Incidence to Drive Stem Cell Transplants
Table 30: Number of New Cancer Cases Worldwide by Affected Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
Demineralized Bone Matrix (DBM): Strong Growth but Tough Competition
Bone Morphogenetic Protein - Safety Concerns Affect Growth Prospects
Dental Bone Grafting - A High Potential Market
Table 31: Global Dental Regeneration Market (2013E): Percentage Share Breakdown of Value Sales for Bone Allografts, Membranes, Tissue Regeneration (includes corresponding Graph/Chart)

3. TECHNOLOGICAL INNOVATIONS
3-D Bioprinting
Preloaded Corneal Tissue Cartridges
Lung Perfusion Technology

4. MAJOR ISSUES IMPACTING TRANSPLANTATION MARKET
Organ Rejection - A Major Barrier to Transplantation
Scarcity of Donor Organs - A Stumbling Block in Organ Transplantation
Other Issues for Organ Transplantation
Ethical Concerns in Transplants
Bioethical Issues Hinder Organ Donation Process
Lack of Requisite Expertise - Hindering Implantation Process
Corneal Transplantation in Developing Countries: Key Challenges

5. PRODUCT OVERVIEW
Organ and Tissue Transplantation
Organ Transplantation
Heart Transplantation
Heart Diseases and Disorders
Post-Operative Complications and Consequences of Heart Transplants
Bleeding
Infection
Arrythymia
Heart Attack
Coronary Artery Disease
Respiratory Dysfunction
Renal Dysfunction
Graft Rejection and Dysfunction
Death
Kidney Transplantation
Kidney Disorders and Diseases
Donor Evaluation
Waiting List
Surgery/Post-Operation
Post-Operative Supervision and Issues
Liver Transplantation
Liver Disorders and Diseases
Pancreas Transplantation
Post-Operative Complications and Consequences of Pancreas Transplants
Small Intestine Transplantation
Intestine Disorders and Diseases
Heart-and-Lung Transplantation
Lung Transplantation
Lung Diseases and Disorders
Lung Patients Survival Statistics
Tissue Transplantation
Types of Grafts
Autograft
Allograft / Homograft
Transplant Tolerance
Isograft
Xenograft
Corneal Transplantation
Penetrating Keratoplasty
Lamellar (Non-Penetrating) Keratoplasty
Aftercare
Risks Associated with Corneal Transplants
Transplantation Outcomes
Morbidity and Mortality Rates
Alternatives
Blood Stem Cells
Peripheral Blood Stem Cell Transplant
Umbilical Cord Blood Stem Cell Transplant
Bone Marrow and Hematopoietic Stem Cells
Bone and Tissue Transplantation
Bone Marrow Transplants
Stem Cell Therapy
Human Heart Valves
Atrioventricular Valves
Mitral Valve
Tricuspid Valve
Semilunar Valves
Aortic Valve
Pulmonic Valve
Pathology of Valves
Prosthetic Heart Valves
Prosthetic Mechanical Valve
Advantages
Disadvantages
Prosthetic Biologic Valve
Advantages
Disadvantages
Fetal Cells
Fetal Tissue for Transplantation
Storage Duration Time
Storage Time Period for Organs and Tissues
Cold Ischemia Time
Transplantation Immunology
Acute Cellular Rejection
Chronic Rejection
Post Transplant Observations
Types of Donors
Alive Donors
Related Donors
Good Samaritans
Rewarded/Forced Donors
Deceased Donors
Directed / Allocated
Organs and Tissues Transplanted by Type of Donor
Organ/Tissue Donation and Eligibility Criteria
Factors Considered for Matching Recipients to Donor Organs
Testing
Blood Typing
Tissue Typing
Histocompatibility - A Major Barrier for Organ Transplantation
Transplantation - Safety Requirements
Waiting List
Active Waiting List Patients
Inactive Waiting List Patients
History

6. ARTIFICIAL ORGANS - AN ALTERNATIVE TO SOLID ORGAN TRANSPLANTS
Artificial Organs Revolutionize Medical Technology Industry
Artificial Organs
Categorization of Artificial Organs
External Artificial Organs
Internal or Implantable Artificial Devices
Artificial Heart
Total Artificial Heart (TAH)
Ventricle Assist Device (VAD)
Right Ventricular Assist Systems (RVAS)
Left Ventricular Assist Systems (LVAS)
Various Ventricle Assist Devices Approved in the Recent Past
Artificial Kidney (Dialyzer)
Limitations of Artificial Kidney
Artificial Liver
Various Liver Assist Devices
Categorization of Liver Devices
Mechanical Systems
Bio-Artificial Systems
Artificial Pancreas
Artificial Lungs (Oxygenator)
Types of Artificial Lung
Artificial Cornea
Keratoprostheses
Tissue Engineered Corneas
Artificial Skin/Skin Replacement Products
AlloDerm Regenerative Tissue Matrix
Apligraf
Cymetra Micronized AlloDerm Tissue
Dermagraft
Epicel
Integra Products
OrCel
TransCyte
Core Competitive Factors
Market Outlook for Artificial Organs

7. PRESERVATION SOLUTIONS & IMMUNOSUPPRESSANT DRUGS
Organ Preservation Solutions
Celsior Solution
Collins Solution
Euro Collins Solution
Custodiol® HTK Solution
Hypothermosol
ViaSpan
Immunosuppressant Drugs
Antibody Products for Treatment of Organ Transplant Rejection
Antithymocyte Globulin
ATGAM
Thymoglobulin
Therapeutic Antibody Products
Antiproliferative Agents
Azathioprine
CellCept
Certican
Myfortic
Calcineurin Inhibitors
Cyclosporine
Gengraf
Neoral
Prograf (Tacrolimus)
TOR Inhibitors
Side Effects of Immunosuppression Therapy
Select Players Engaged in Immunosuppressant Drugs/Ant
Rejection Therapy/ Bridge-to- Transplantation Devices
Astellas Pharma US, Inc. (USA)
F.Hoffmann-La Roche Ltd. (Switzerland)
Novartis AG (Switzerland)
Wyeth (USA)
Abiomed, Inc. (USA)
Fresenius Medical Care AG & Co. KGaA (Germany)
Gambro AB (Sweden)
Genzyme Corporation (US)
Jarvik Heart, Inc. (US)
ReliantHeart (US)
SynCardia Systems (US)
Terumo Corporation (Japan)
Teleflex Inc. (US)
Thoratec Corporation (US)
Heart Ware International, Inc. (US)

8. REGULATORY ENVIRONMENT
Transplant Center
Organ Procurement Organization (OPO)
Health Resources and Services Administration (HRSA)
Division of Transplantation (DoT)
United Network for Organ Sharing (UNOS)
Organ Procurement and Transplantation Network (OPTN)
University Renal Research and Education Association (URREA)
Scientific Registry of Transplant Recipients (SRTR)
Funding Sources
Patient Education and Advocacy Organizations
Legal Framework for Transplantation
Legislation Covering Organ Transplant
Organ Transplantation and Ethics

9. PRODUCT DEVELOPMENT/INNOVATIONS
AlloSource Introduces AlloMend™
Synergy Biomedical Launches Bonegraft Product BioSphere Putty
K2M Launches Venado Bonegraft Systems
OTS Launches LifeCradle® Heart Perfusion System
BioHorizons Launches MinerOss® Cancellous Dental Grafts
K2M Launches Vesuvius Graft Systems
OTTR Launches Pediatric BMT System
Amedica to Begin Distribution of Dynamic Bone
BioMimetic Introduces Augmatix Bonegraft
Integra Introduces Integra® Allograft Wedge System

10. RECENT INDUSTRY ACTIVITY
ThermoGenesis and TotipotentRX Complete 20th Pediatric BMT
LifeCell Acquires Adipose Tissue Injector from Tau Tona Group
FBiH Signs Agreement with Croatia
AlloSource and HumaCyte Enter Manufacturing Agreement
PSF Partners with MTF for Research Grants
Wright Medical Partners with BioMimetic Therapeutics
Pharmalink Signs Manufacturing Agreement with GP Pharm
Isotechnika Pharma Ends Agreement with ILJIN
Veloxis Starts STRATO Study in Kidney-Transplant Recipients
Isotechnika Signs Voclosporin License Agreement with Vifor Pharma

11. FOCUS ON SELECT GLOBAL PLAYERS
CryoLife, Inc.(US)
Exactech, Inc. (US)
Folio Biosciences (US)
Köhler Chemie (Germany)
LifeCell Corporation (US)
Medtronic, Inc. (US)
Organogenesis, Inc. (US)
Organ Recovery Systems (US)
Organ Transport Systems (US)
XVIVO Perfusion AB (Sweden)

12. GLOBAL MARKET PERSPECTIVE
Table 32: World Recent Past, Current & Future Analysis for Organ Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 33: World Historic Review for Organ Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 34: World 15-Year Perspective for Organ Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 35: World Recent Past, Current & Future Analysis for Heart Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 36: World Historic Review for Heart Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 37: World 15-Year Perspective for Heart Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 38: World Recent Past, Current & Future Analysis for Kidney Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 39: World Historic Review for Kidney Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 40: World 15-Year Perspective for Kidney Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 41: World Recent Past, Current & Future Analysis for Liver Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 42: World Historic Review for Liver Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 43: World 15-Year Perspective for Liver Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 44: World Recent Past, Current & Future Analysis for Pancreas Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 45: World Historic Review for Pancreas Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 46: World 15-Year Perspective for Pancreas Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 47: World Recent Past, Current & Future Analysis for Lung Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 48: World Historic Review for Lung Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 49: World 15-Year Perspective for Lung Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 50: World Recent Past, Current & Future Analysis for Corneal Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 51: World Historic Review for Corneal Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 52: World 15-Year Perspective for Corneal Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES
A.Market Analysis
Organ Transplants Market in the US
Organ Transplants by Donor
Table 53: The US Organ Donors per 1 Million Population by Type - Kidney, Liver, Heart, Lung, and Pancreas for the Years 2011, 2012 & 2013 (includes corresponding Graph/Chart)
Table 54: The US Bone Marrow Donor Registry: Percentage Breakdown of Adult Donors and Cord Blood Units by Race/Ethnicity (includes corresponding Graph/Chart)
Table 55: The US Kidney Transplants by Donor Type
Deceased and Living: Number of Procedures for 2012, 2013, and 2014 E (includes corresponding Graph/Chart)
Table 56: The US Kidney Transplants by Donor Type
Deceased and Living: Percentage Share Breakdown of Number of Procedures for 2012, 2013, and 2014 E (includes corresponding Graph/Chart)
Table 57: The US Liver Transplants by Donor Type - Deceased and Living: Number of Procedures for 2012, 2013, and 2014 E (includes corresponding Graph/Chart)
Table 58: The US Liver Transplants by Donor Type - Deceased and Living: Percentage Share Breakdown of Number of Procedures for 2012, 2013, and 2014 E (includes corresponding Graph/Chart)
Table 59: The US Heart Transplants by Donor Type - Deceased and Living: Number of Procedures for 2012, 2013, and 2014 E (includes corresponding Graph/Chart)
Table 60: The US Heart Transplants by Donor Type - Deceased and Living: Percentage Share Breakdown of Number of Procedures for 2012, 2013, and 2014 E
Table 61: The US Lung Transplants by Donor Type - Deceased and Living: Number of Procedures for 2012, 2013, and 2014 E (includes corresponding Graph/Chart)
Table 62: The US Lung Transplants by Donor Type - Deceased and Living: Percentage Share Breakdown of Number of Procedures for 2012, 2013, and 2014 E (includes corresponding Graph/Chart)
Table 63: The US Pancreas Transplants by Donor Type
Deceased and Living: Number of Procedures for 2012, 2013, and 2014 (Aug ’14) (includes corresponding Graph/Chart)
Table 64: The US Pancreas Transplants by Donor Type
Deceased and Living: Percentage Share Breakdown of Number of Procedures for 2012, 2013, and 2014 E (includes corresponding Graph/Chart)
Table 65: The US Intestinal Transplants by Donor Type
Deceased and Living: Number of Procedures for 2012, 2013, and 2014 (Aug ’14) (includes corresponding Graph/Chart)
Table 66: The US Intestinal Transplants by Donor Type
Deceased and Living: Percentage Share Breakdown of Number of Procedures for 2012, 2013, and 2014 E (includes corresponding Graph/Chart)
Waiting List
Table 67: Waiting List of Patients for Organ Transplants by Organ Type: as of August 2014 (includes corresponding Graph/Chart)
Select Market Trends
Rising Incidence of ESRD in the US: A Business Case for Kidney Transplants
Table 68: ESRD Patient Prevalence in the US (2010-2015) (includes corresponding Graph/Chart)
Innovative Means of Organ Procurement to Increase Organ Donations
KPD Enables Compatibility Factor for Kidney Transplants
Awareness Programs to Address Shortage of Minority Donors
US Organ Procurement Organizations by State
Tissue Transplantation in the US
Dental Bone Graft Substitutes Market: An Overview
Regulatory Challenges Limit Growth in the US Orthopedic Biomaterials Market
Rising Incidence of Degenerative Intervertebral Disc Diseases-Opportunity Indicators for Bone Grafts
Osteoporosis
Table 69: Osteoporosis Population in the US: 2002, 2005, 2008 & 2012 (includes corresponding Graph/Chart)
Table 70: Breakdown of Osteoporotic Fractures by Site in the US (includes corresponding Graph/Chart)
Regulatory Bodies
The United Network for Organ Sharing
The American Association of Tissue Banks (AATB)
National Organ Transplant Act (NOTA)
Good Tissue Practices
Tissue Banking Regulation
FDA Regulations on Xenograft
DBM-based Products in US
Synthetic Bone Graft Substitutes
Product Launches
Strategic Corporate Developments
Select Key Players
B.Market Analytics
By Value Sales
Table 71: The US Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 72: The US Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 73: The US 15-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Dollar Sales for Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 74: The US Recent Past, Current & Future Analysis for Tissue Transplantation Market Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 75: The US Historic Review for Tissue Transplantation Market Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
By Number of Procedures
Table 76: The US Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 77: The US Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 78: The US 15-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 79: The US Recent Past, Current & Future Analysis for Tissue Transplantation by Tissue Type - Cornea, Heart Valves, Skin Grafts, Vascular Grafts, Bone Marrow and Bone Grafts Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 80: The US Historic Review for Tissue Transplantation by Tissue Type - Cornea, Heart Valves, Skin Grafts, Vascular Grafts, Bone Marrow and Bone Grafts Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 81: The US 15-Year Perspective for Tissue Transplantation by Tissue Type - Percentage Breakdown of Number of Procedures for Cornea, Heart Valves, Skin Grafts, Vascular Grafts, Bone Marrow and Bone Grafts Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 82: The US Recent Past, Current & Future Analysis for Bone Graft Transplantation by Graft Type - Autologous Graft, Allograft and Other Materials Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 83: The US Historic Review for Bone Graft Transplantation by Graft Type - Autologous Graft, Allograft and Other Materials Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 84: The US 15-Year Perspective for Bone Graft Transplantation by Graft Type - Percentage Breakdown of Number of Procedures for Autologous Graft, Allograft and Other Materials Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 85: The US Recent Past, Current & Future Analysis for Bone Graft Transplantation by Application - General Orthopedics, Spinal Fusions and Cranio/Maxillofacial Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 86: The US Historic Review for Bone Graft Transplantation by Application - General Orthopedics, Spinal Fusions and Cranio/ Maxillofacial Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 87: The US 15-Year Perspective for Bone Graft Transplantation by Application - Percentage Breakdown of Number of Procedures for General Orthopedics, Spinal Fusions and Cranio/Maxillofacial Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

2. CANADA
A.Market Analysis
Canadians More Receptive to Organ Transplants
Table 88: Canadian Organ Donors by Donor Type - Deceased and Living for Years 2011& 2012 (includes corresponding Graph/Chart)
Table 89: Canadian Deceased Organ Donors by Age Group (2011 & 2012) (includes corresponding Graph/Chart)
Table 90: Canadian Living Organ Donors by Age Group (2011 & 2012) (includes corresponding Graph/Chart)
Table 91: Canadian Multiple Organ Transplants by Type in Terms of Number of Transplants: 2012 (includes corresponding Graph/Chart)
Small Intestine Transplants
Table 92: Canadian Intestinal Transplants by Transplant Type and Age Group (2003-2012) (includes corresponding Graph/Chart)
Waiting List
Table 93: Canadian Patients on Active Waiting List for Organ Transplants by Type: 2012 (includes corresponding Graph/Chart)
Table 94: Canadian Patients on Active Waiting List for Combination Organ Transplants by Type (2012) (includes corresponding Graph/Chart)
Success Rate of Organ Transplants
Table 95: Success Rate of Organ Transplants after 1-Year (includes corresponding Graph/Chart)
Favorable Growth Prospects in Bone Graft Substitutes Market
B.Market Analytics
Table 96: Canadian Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 97: Canadian Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 98: Canadian 15-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

3. EUROPE
A.Market Analysis
Table 99: European Deceased Organ Donor Per Million Population (PMP) by Country for 2011, 2012 & 2013 (includes corresponding Graph/Chart)
Table 100: European Living Organ Donor Per Million Population (PMP) by Country for 2013 (includes corresponding Graph/Chart)
Table 101: European Single Organ Transplantations by Select Country and Organ Type: 2013 (includes corresponding Graph/Chart)
Table 102: European Multi-Organ Transplantations by Select Country and Transplant Type: 2013 (includes corresponding Graph/Chart)
Table 103: European Organ Transplantation Waiting Lists: No. of Waiting Patients by Organ Type (2012) (includes corresponding Graph/Chart)
Orthopedic Biomaterials Market - Overview
Table 104: European Bone Graft Substitutes Market (2012): Percentage Share Breakdown of Value Sales for Synthetic, Allograft, and DBM (includes corresponding Graph/Chart)
Synthetic Bone Graft Market Drives the BGS Market
Dental Biomaterials Market in Europe: An Insight
Medical Tourism Bodes Well for Dental Implants Market
Turkey - Fastest Growing Dental Implant Market
Competitive Scenario
Key Statistical Data
Table 105: European Market for Standard Bone Allografts (2012): Percentage Share Breakdown of Revenues by Leading Companies/Organizations (includes corresponding Graph/Chart)
Table 106: European Market for Machined Bone Allografts (2012): Percentage Share Breakdown of Revenues by Leading Companies/Organizations (includes corresponding Graph/Chart)
Table 107: European Market for Demineralized Bone Matrix (2012): Percentage Market Share Breakdown of Revenues by Leading Companies/ Organizations (includes corresponding Graph/Chart)
Table 108: European Market for Bone Graft Substitutes (2012): Percentage Share Breakdown of Value Sales by Leading Players (includes corresponding Graph/Chart)
Regulatory Overview
EU Directive 2003/32/EC on Bone Grafts
DBM-based Products in Europe & Rest of World
Focus On Select Regions
The United Kingdom
UK Organ Transplantation System: An Overview
Organ Transplantation Statistics in the UK
Table 109: The UK Organ Donors by Type (April 2012 & April 2013) (includes corresponding Graph/Chart)
Table 110: The UK Organ Transplantation by Organ Type: 2012 Vs. 2013 (includes corresponding Graph/Chart)
Table 111: The UK Active Transplant Waiting List by Organ: As of April 2012 and April 2013 (includes corresponding Graph/Chart)
Table 112: The UK Deceased Donor Kidney Program (March 2010-March 2013) - No. of Kidney Donors, No. of Patients on Active Waiting List, and No. of Kidney Transplants (includes corresponding Graph/Chart)
Corneal Transplantation in the UK
Spain
Organ Transplantation in Spain
France
Table 113: Organ Transplantations in France by Organ Type: 2012 (includes corresponding Graph/Chart)
Table 114: Transplant Waiting List by Organ in France: 2012 (includes corresponding Graph/Chart)
Table 115: Transplants from Living Donors by Organ Type in France: 2012 (includes corresponding Graph/Chart)
Italy
Surge in Organ Transplants
Russia
Organ Transplantations Show a Downward Trend in Russia
Turkey
Table 116: Turkey - High PMP Numbers of Living Organ Donors/Transplants (includes corresponding Graph/Chart)
Akdeniz University - A World-Renowned Transplantation Center
Strategic Corporate Developments
Select Key Players
B.Market Analytics
Table 117: European Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 118: European Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 119: European 15-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4. ASIA-PACIFIC
A.Market Analysis
Table 120: Asia-Pacific Deceased Organ Donor Per Million Population (PMP) by Country for 2011, 2012 & 2013 (includes corresponding Graph/Chart)
Table 121: Asia-Pacific Living Organ Donor Per Million Population (PMP) by Country for 2011, 2012 & 2013 (includes corresponding Graph/Chart)
Focus on Select Regions
Australia - One of the Major Organ Transplant Markets in Asia-Pacific
Key Facts on Organ and Tissue Transplantation in Australia
Australia Registers Highest Success Rate in Transplantation
Table 122: Australia Organ Transplantations by Organ Type: 2013 (includes corresponding Graph/Chart)
Table 123: Australian Organ Transplants by State: 2013 (includes corresponding Graph/Chart)
Thriving Orthopedic Biomaterials Market in Asia-Pacific
China
Organ Transplantations in China: Years 2010 to 2013 in Review
Origin
Transplantation Tourism in China
Low Transplant Success Rate Due to Unskilled Professionals
Cost Effective Transplant Procedures Lure Foreign Patients
Illegal Activities for Harvesting Organs in China
Regulations on Organ Transplantation
Regulations on Brain Death
India
Overview of Renal Transplantation
Transplantation Expenses in India
Indian Government to Amend Organ Transplantation Rules
Rise in Medical Tourism Drives Bone Grafts Market
Aging Population Boosts the Indian Orthopedic Market
Singapore
Awareness Programs to Increase Living Kidney Donations in Singapore
Terumo Corporation (Japan) - A Key Player
B.Market Analytics
Table 124: Asia-Pacific Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 125: Asia-Pacific Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 126: Asia-Pacific 15-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

5. LATIN AMERICA
A.Market Analysis
Brazil - A Major Transplant Market
Dental Bone Graft Substitutes Market - Overview
B.Market Analytics
Table 127: Latin American Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 128: Latin American Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 129: Latin American 15-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

6. REST OF WORLD
A.Market Analysis
Kuwait - A Rapidly Emerging ‘Third World’ Country in Organ Transplants
Iran - “Kidney E-Bay”
South Africa
Key Statistical Findings on Organ and Cornea Transplants
Table 130: Incidence of Deceased Organ Donor per million population in Africa/ Middle East by Country for 2011, 2012 & 2013 (includes corresponding Graph/Chart)
Table 131: Incidence of Living Organ Donor per million population in Africa/Middle East by Country for 2012 & 2013 (includes corresponding Graph/Chart)
Table 132: Number of Organ and Corneal Transplants in South Africa by Organ Type: 2011&2012 (includes corresponding Graph/Chart)
Table 133: Number of Organ and Corneal Transplants in Adult Patients in South Africa by Organ: 2011 & 2012 (includes corresponding Graph/Chart)
Table 134: Number of Organ Transplants in Adolescent Patients in South Africa by Organ: 2011&2012 (includes corresponding Graph/Chart)
Table 135: Number of Organ Transplants in Pediatric Patients in South Africa by Organ: 2011&2012 (includes corresponding Graph/Chart)
B.Market Analytics
Table 136: Rest of World Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 137: Rest of World Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 138: Rest of World 15-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 24
The United States (21)
Europe (2)
- Germany (1)
- Rest of Europe (1)
Middle East (1)

Note: Product cover images may vary from those shown

- CryoLife, Inc.
- Exactech, Inc.
- Folio Biosciences
- Köhler Chemie
- LifeCell Corporation

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos